Evidence map›Paper›PMID 31131346›Full record

ArticleJBMR plus2019

Combination Therapy With Zoledronic Acid and FES-Row Training Mitigates Bone Loss in Paralyzed Legs: Results of a Randomized Comparative Clinical Trial.

L R Morse, K L Troy, Y Fang, N Nguyen, R Battaglino, R F Goldstein, R Gupta, J A Taylor

Abstract read
In one paragraph

Article in JBMR plus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Effect of External Mechanical Stimuli on Human Bone: a narrative review.Progress in biomedical engineering (Bristol, England) · 2022
    Article
  7. Article
  8. Functional electrical stimulation (FES)-assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  9. Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches.Journal of musculoskeletal & neuronal interactions · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

L R MorseRocky Mountain Regional Spinal Injury System Craig Rehabilitation Hospital Englewood CO USA.
K L TroyDepartment of Biomedical Engineering Worcester Polytechnic Institute Worcester MA USA.
Y FangDepartment of Biomedical Engineering Worcester Polytechnic Institute Worcester MA USA.
N NguyenRocky Mountain Regional Spinal Injury System Craig Rehabilitation Hospital Englewood CO USA.
R BattaglinoDepartment of PMR University of Colorado School of Medicine Aurora CO USA.
R F GoldsteinRocky Mountain Regional Spinal Injury System Craig Rehabilitation Hospital Englewood CO USA.
R GuptaDepartment of Radiology Massachusetts General Hospital Boston MA USA.
J A TaylorSpaulding Rehabilitation Hospital Boston MA USA.

Funding

Regulation of Gastric and Osteoclat Acidification by Snx10R01AR064793 · NIAMS · UNIVERSITY OF MINNESOTA · PI BATTAGLINO, RICARDO ANIBAL · 2015 to 2021
$3.2M
NIAMS NIH HHS R01 AR064793NICHD NIH HHS L30 HD056721
6 · The paper itself

Abstract

Spinal cord injury (SCI) results in rapid, severe osteoporosis and an increased risk of lower extremity fractures. Despite the medical complications associated with these fractures, there is no standard of care to prevent osteoporotic fractures following SCI. Functional electrical stimulation- (FES-) assisted rowing is a promising intervention to improve bone health in SCI because of its ability to generate a muscular contraction in conjunction with mechanical loading of the lower extremity long bones. Combination therapy consisting of FES-rowing plus zoledronic acid (ZA) may be a superior treatment via inhibition of bone resorption and stimulation of new bone formation. We studied participants enrolled in a randomized clinical trial comparing FES-rowing alone with FES-rowing plus ZA to improve bone health in SCI. Volumetric CT scans at the distal femur and proximal tibial metaphyses were performed. Bone geometric properties (cortical thickness index [CTI], cortical compressive strength index [CSI], buckling ratio [BR], bending strength index) and mineral (cortical bone volume [CBV], cortical bone mineral density, cortical bone mineral content) indices were determined. In models adjusting for baseline values, we found that the CBV (

Indexed as

ANTIRESORPTIVESBONE QCTCLINICAL TRIALSOSTEOPOROSISTHERAPEUTICS

Identifiers

PMID31131346
PMCPMC6524678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.